Ryman Healthcare Limited (RHCGF)
Ryman Healthcare Statistics
Share Statistics
Ryman Healthcare has 1.01B shares outstanding. The number of shares has increased by 47.93% in one year.
| Shares Outstanding | 1.01B |
| Shares Change (YoY) | 47.93% |
| Shares Change (QoQ) | 47.75% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 482.43 and the forward PE ratio is null. Ryman Healthcare's PEG ratio is -4.89.
| PE Ratio | 482.43 |
| Forward PE | n/a |
| PS Ratio | 5.92 |
| Forward PS | n/a |
| PB Ratio | 0.87 |
| P/FCF Ratio | 10.18 |
| PEG Ratio | -4.89 |
Enterprise Valuation
Ryman Healthcare has an Enterprise Value (EV) of 4.85B.
| EV / Sales | 12.47 |
| EV / EBITDA | -88.92 |
| EV / EBIT | 14.73 |
| EV / FCF | 21.42 |
Financial Position
The company has a current ratio of 3.26, with a Debt / Equity ratio of 0.97.
| Current Ratio | 3.26 |
| Quick Ratio | 3.25 |
| Debt / Equity | 0.97 |
| Debt / EBITDA | -47.12 |
| Debt / FCF | 11.35 |
| Interest Coverage | -0.54 |
Financial Efficiency
Return on Equity is 0.18% and Return on Invested Capital is 0.01%.
| Return on Equity | 0.18% |
| Return on Assets | 0.06% |
| Return on Invested Capital | 0.01% |
| Revenue Per Employee | $50,496.65 |
| Profits Per Employee | $620.13 |
| Employee Count | 7,700 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 273.21 |
Taxes
| Income Tax | -89.48M |
| Effective Tax Rate | 103.29% |
Stock Price Statistics
The stock price has increased by -57.91% in the last 52 weeks. The beta is 0.46, so Ryman Healthcare's price volatility has been higher than the market average.
| Beta | 0.46 |
| 52-Week Price Change | -57.91% |
| 50-Day Moving Average | 1.72 |
| 200-Day Moving Average | 2.4 |
| Relative Strength Index (RSI) | 13.86 |
| Average Volume (20 Days) | 627 |
Income Statement
In the last 12 months, Ryman Healthcare had revenue of 388.82M and earned 4.78M in profits. Earnings per share was 0.
| Revenue | 388.82M |
| Gross Profit | -1.06M |
| Operating Income | -26.99M |
| Net Income | 4.78M |
| EBITDA | -54.52M |
| EBIT | -80.7M |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 25.01M in cash and 2.57B in debt, giving a net cash position of -2.54B.
| Cash & Cash Equivalents | 25.01M |
| Total Debt | 2.57B |
| Net Cash | -2.54B |
| Retained Earnings | 1.86B |
| Total Assets | 7.82B |
| Working Capital | 305.93M |
Cash Flow
In the last 12 months, operating cash flow was 329.2M and capital expenditures -93.67M, giving a free cash flow of 226.28M.
| Operating Cash Flow | 329.2M |
| Capital Expenditures | -93.67M |
| Free Cash Flow | 226.28M |
| FCF Per Share | 0.33 |
Margins
Gross margin is -0.27%, with operating and profit margins of -6.94% and 1.23%.
| Gross Margin | -0.27% |
| Operating Margin | -6.94% |
| Pretax Margin | -22.28% |
| Profit Margin | 1.23% |
| EBITDA Margin | -14.02% |
| EBIT Margin | -6.94% |
| FCF Margin | 58.2% |
Dividends & Yields
RHCGF pays an annual dividend of $0.31, which amounts to a dividend yield of 4.52%.
| Dividend Per Share | $0.31 |
| Dividend Yield | 4.52% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | -445.71% |
| Earnings Yield | 0.21% |
| FCF Yield | 9.82% |
Analyst Forecast
Currently there are no analyst rating for RHCGF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Feb 24, 2023. It was a forward split with a ratio of 53:50.
| Last Split Date | Feb 24, 2023 |
| Split Type | forward |
| Split Ratio | 53:50 |
Scores
| Altman Z-Score | 0.88 |
| Piotroski F-Score | 6 |